| Date Filed | Type | Description |
| 09/13/2022 |
4
| Daruwala Paul (COO) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Sold 16,199 shares
@ $0.6849, valued at
$11.1k
|
|
| 04/04/2022 |
4
| Daruwala Paul (COO) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Granted 50,000 shares
@ $0
Granted 100,000 options to buy
@ $0.83, valued at
$83k
|
|
| 01/07/2022 |
4
| Daruwala Paul (COO) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Sold 5,133 shares
@ $1.25, valued at
$6.4k
Exercised 5,000 restricted stock units
@ $0
Exercised 4,900 restricted stock units
@ $0 |
|
| 10/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2020 |
4/A
| Daruwala Paul (COO) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Sold 940 shares
@ $3.42, valued at
$3.2k
|
|
| 03/23/2020 |
4
| Daruwala Paul (COO) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Granted 90,000 options to buy
@ $1.98, valued at
$178.2k
|
|
| 01/06/2020 |
4
| Daruwala Paul (COO) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Sold 2,340 shares
@ $3.42, valued at
$8k
|
|
| 12/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/16/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/22/2019 |
4
| Daruwala Paul (COO) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Granted 77,000 options to buy
@ $2.61, valued at
$201k
|
|
| 03/08/2019 |
4
| Daruwala Paul (COO) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Sold 2,240 shares
@ $2.5507, valued at
$5.7k
|
|
| 02/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/02/2018 |
4
| Daruwala Paul (COO) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Granted 72,000 options to buy
@ $4, valued at
$288k
|
|
| 09/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/18/2016 |
4
| Daruwala Paul (Chief Commercial Officer) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $9.89, valued at
$494.5k
|
|